Business
Currency:USD
2025/Q2
Stock NameRevenueRatio
Sterilization and Disinfection Control22.21M38.40%
Calibration Solutions12.26M21.20%
Biopharmaceutical Development11.87M20.52%
Clinical Genomics11.5M19.88%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States106.4M49.21%
Other84.86M39.25%
People's Republic of China24.93M11.53%
